Jarrett Allen

#31 C

Cleveland Cavaliers

Status

ACTIVE

Previous game (@ ORL 4/27)

PTS

REB

AST

BLK

STL

Latest Jarrett Allen news

Allen agreed to a three-year, $91 million maximum extension with the Cavaliers on Wednesday, Adrian Wojnarowski of ESPN reports. Allen recorded career-best marks in several areas during the 2023-24 season, averaging 16.5 points, 10.5 rebounds and 2.7 assists in 31.7 minutes per game over 77 regular-season appearances. He's now under contract with the Cavaliers through the 2028-29 season and should maintain a prominent role with the team after averaging over 30 minutes per game over his first three full seasons with the club. Cleveland has now signed Allen, Donovan Mitchell and Evan Mobley to extensions this summer, so the team's core should remain intact for years to come.

2023-24 Postseason Stats

PTS

REB

AST

BLK

STL

17.0

13.8

1.3

1.0

1.3

2023-24 Season Stats

PTS

REB

AST

BLK

STL

16.5

10.5

2.7

1.1

0.7

1.6

Career Averages

PTS

REB

AST

BLK

STL

12.7

9.1

1.6

1.3

0.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	77	77	31.7	16.5	10.5	2.7	1.1	0.7	1.6	42	0.0	0.1	0.0%	6.7	10.6	63.8%	6.7	10.6	63.4%	3.0	4.1	74.2%	3.2	7.4	1.9	1.7	+200	66.4%
2022-23	68	68	32.6	14.3	9.8	1.7	1.2	0.8	1.4	32	0.0	0.1	10.0%	5.9	9.1	65.3%	5.9	9.2	64.4%	2.4	3.3	73.3%	3.3	6.5	2.3	1.2	+345	67.0%
2021-22	56	56	32.3	16.1	10.8	1.6	1.3	0.8	1.7	32	0.0	0.2	10.0%	6.6	9.6	68.8%	6.6	9.7	67.7%	2.9	4.2	70.8%	3.4	7.3	1.7	1.0	+135	69.8%
2020-21	63	45	29.6	12.8	10.0	1.7	1.4	0.5	1.6	25	0.1	0.3	31.6%	4.6	7.3	63.1%	4.7	7.7	61.8%	3.2	4.6	70.3%	3.1	6.9	1.5	1.1	-203	66.1%
2019-20	70	64	26.5	11.1	9.6	1.6	1.3	0.6	1.1	30	0.0	0.1	0.0%	4.3	6.6	65.8%	4.3	6.6	64.9%	2.4	3.9	63.3%	3.1	6.5	2.3	1.4	+45	66.4%
2018-19	80	80	26.2	10.9	8.4	1.4	1.5	0.5	1.3	24	0.1	0.6	13.3%	4.1	6.5	62.9%	4.2	7.1	59.0%	2.5	3.5	70.9%	2.4	6.0	2.3	1.1	-119	63.2%
2017-18	72	31	20.0	8.2	5.4	0.7	1.2	0.4	1.1	4	0.1	0.2	33.3%	3.2	5.3	59.9%	3.3	5.5	58.9%	1.6	2.0	77.6%	2.0	3.4	2.0	0.6	-142	63.6%
Career	486	421	28.2	12.7	9.1	1.6	1.3	0.6	1.4	189	0.0	0.2	17.1%	5.0	7.8	64.4%	5.1	8.0	63.0%	2.6	3.6	71.1%	2.9	6.3	2.0	1.2	+261	66.2%

Career Averages

PTS

REB

AST

BLK

STL

11.7

10.3

2.1

1.1

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	4	4	31.8	17.0	13.8	1.3	1.0	1.3	1.3	2	0.0%	6.3	9.3	67.6%	6.3	9.3	67.6%	4.5	6.5	69.2%	3.8	10.0	2.0	1.0	-8	70.2%
2022-23	5	5	38.2	9.4	7.4	2.4	1.0	0.8	0.6	1	0.0%	4.4	7.2	61.1%	4.4	7.2	61.1%	0.6	1.2	50.0%	3.0	4.4	2.0	4.0	-28	60.8%
2019-20	4	4	33.0	10.3	14.8	2.3	1.8	0.5	2.8	2	0.0%	3.5	6.0	58.3%	3.5	6.0	58.3%	3.3	4.0	81.3%	4.3	10.5	1.8	0.8	-33	66.0%
2018-19	5	5	22.0	11.0	6.8	2.2	0.6	0.6	1.6	0	0.0%	3.8	6.4	59.4%	3.8	6.4	59.4%	3.4	4.0	85.0%	3.0	3.8	2.6	1.4	-60	67.4%
Career	18	18	31.1	11.7	10.3	2.1	1.1	0.8	1.5	5	0.0%	4.4	7.2	62.0%	4.4	7.2	62.0%	2.8	3.8	75.0%	3.4	6.8	2.1	1.4	-129	66.4%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/14	CHA	L 120-110	22	14	7	2	0	2	3	0	0	0.0%	7	7	100.0%	7	7	100.0%	0	0	0.0%	1	6	0.7	+9	1	21	100.0%
4/12	IND	W 129-120	38	29	13	3	0	0	2	0	0	0.0%	14	13	92.9%	14	13	92.9%	8	3	37.5%	3	10	1.5	+8	2	40	82.8%
4/10	MEM	W 110-98	33	16	10	5	3	0	1	1	0	0.0%	12	7	58.3%	13	7	53.8%	2	2	100.0%	6	4	5.0	-2	1	23	57.6%
4/7	LAC	L 120-118	34	17	10	1	1	1	1	0	0	0.0%	12	6	50.0%	12	6	50.0%	5	5	100.0%	2	8	1.0	-1	1	28	59.9%
4/6	LAL	L 116-97	33	12	12	3	0	1	1	0	0	0.0%	12	6	50.0%	12	6	50.0%	0	0	0.0%	5	7	3.0	-5	2	16	50.0%
4/3	PHX	L 122-101	37	20	5	4	0	0	0	0	0	0.0%	15	9	60.0%	15	9	60.0%	2	2	100.0%	3	2	0.0	-10	2	22	63.0%
4/2	UTA	W 129-113	33	21	12	5	0	1	0	0	0	0.0%	11	8	72.7%	11	8	72.7%	6	5	83.3%	4	8	0.0	+26	0	40	77.0%
3/31	DEN	L 130-101	26	19	4	1	1	0	2	0	0	0.0%	15	9	60.0%	15	9	60.0%	2	1	50.0%	0	4	0.5	-24	2	16	59.8%
3/29	PHI	W 117-114	26	13	11	2	0	0	2	0	0	0.0%	9	6	66.7%	9	6	66.7%	1	1	100.0%	1	10	1.0	-6	1	22	68.9%
3/27	CHA	L 118-111	34	24	8	3	0	1	1	0	0	0.0%	14	11	78.6%	14	11	78.6%	4	2	50.0%	3	5	3.0	-6	2	32	76.1%
3/25	CHA	W 115-92	33	17	13	4	0	1	0	0	0	0.0%	9	7	77.8%	9	7	77.8%	3	3	100.0%	2	11	0.0	+14	1	36	82.4%
3/24	MIA	L 121-84	22	9	4	3	0	0	2	0	0	0.0%	7	3	42.9%	7	3	42.9%	4	3	75.0%	0	4	1.5	-17	1	12	51.4%
3/22	MIN	L 104-91	32	15	13	5	1	0	0	0	0	0.0%	10	5	50.0%	10	5	50.0%	6	5	83.3%	5	8	0.0	-18	1	27	59.3%
3/20	MIA	L 107-104	38	25	20	3	0	0	2	0	0	0.0%	13	10	76.9%	13	10	76.9%	6	5	83.3%	2	18	1.5	+4	2	49	79.9%
3/18	IND	W 108-103	33	23	9	1	1	1	1	0	0	0.0%	12	8	66.7%	12	8	66.7%	8	7	87.5%	0	9	1.0	-3	0	36	74.1%
3/16	HOU	L 117-103	26	10	7	0	3	0	3	0	0	0.0%	7	4	57.1%	7	4	57.1%	2	2	100.0%	0	7	0.0	-14	2	15	63.5%
3/13	NOP	W 116-95	31	17	10	1	2	0	1	0	0	0.0%	13	8	61.5%	13	8	61.5%	2	1	50.0%	2	8	1.0	+4	1	25	61.2%
3/11	PHX	L 117-111	37	15	10	2	0	1	1	0	0	0.0%	7	5	71.4%	7	5	71.4%	6	5	83.3%	4	6	2.0	-4	3	26	77.8%
3/10	BKN	L 120-101	28	15	9	3	2	0	1	0	0	0.0%	11	6	54.5%	11	6	54.5%	4	3	75.0%	2	7	3.0	-2	2	24	58.8%
3/8	MIN	W 113-104	46	33	18	3	2	2	1	0	0	0.0%	19	9	47.4%	19	9	47.4%	21	15	71.4%	5	13	3.0	+21	1	53	58.4%
3/6	ATL	L 112-101	37	18	19	3	1	0	3	0	0	0.0%	11	7	63.6%	11	7	63.6%	5	4	80.0%	6	13	1.0	-1	0	38	68.2%
3/5	BOS	W 105-104	35	21	12	2	1	0	0	0	0	0.0%	16	9	56.3%	16	9	56.3%	3	3	100.0%	4	8	0.0	-4	0	30	60.6%
3/3	NYK	L 107-98	35	18	7	6	1	1	1	0	0	0.0%	13	8	61.5%	13	8	61.5%	4	2	50.0%	1	6	6.0	-5	1	27	61.0%
3/1	DET	W 110-100	34	9	15	2	1	1	2	0	0	0.0%	7	1	14.3%	7	1	14.3%	8	7	87.5%	4	11	1.0	-4	1	22	42.8%
2/28	CHI	L 132-123	34	11	4	4	2	1	0	0	0	0.0%	12	5	41.7%	12	5	41.7%	2	1	50.0%	1	3	0.0	-13	3	14	42.7%
2/27	DAL	W 121-119	32	19	9	0	1	0	1	0	0	0.0%	9	7	77.8%	9	7	77.8%	6	5	83.3%	4	5	0.0	-12	0	27	81.6%
2/25	WAS	W 114-105	36	22	12	5	1	0	1	0	0	0.0%	18	11	61.1%	18	11	61.1%	2	0	0.0%	2	10	5.0	+15	3	28	58.3%
2/23	PHI	L 104-97	35	24	9	0	1	0	1	0	0	0.0%	16	10	62.5%	16	10	62.5%	8	4	50.0%	0	9	0.0	-4	3	26	61.5%
2/22	ORL	L 116-109	34	18	10	1	0	2	2	0	0	0.0%	10	6	60.0%	10	6	60.0%	8	6	75.0%	2	8	0.5	+9	1	28	66.6%
2/14	CHI	W 108-105	35	13	10	3	1	1	0	1	0	0.0%	8	6	75.0%	9	6	66.7%	2	1	50.0%	1	9	0.0	+9	1	26	65.8%
2/12	PHI	L 123-121	37	21	10	3	1	0	3	0	0	0.0%	13	9	69.2%	13	9	69.2%	4	3	75.0%	4	6	1.0	+10	2	28	71.1%
2/10	TOR	W 119-95	30	18	15	2	1	0	1	1	0	0.0%	11	9	81.8%	12	9	75.0%	2	0	0.0%	6	9	2.0	+4	2	33	69.9%
2/8	BKN	W 118-95	29	14	10	2	2	0	2	1	0	0.0%	5	3	60.0%	6	3	50.0%	8	8	100.0%	2	8	1.0	+17	2	29	73.5%
2/7	WAS	W 114-106	37	12	9	2	2	0	3	1	0	0.0%	11	5	45.5%	12	5	41.7%	4	2	50.0%	3	6	0.7	-4	1	15	43.6%
2/5	SAC	W 136-110	29	19	7	3	2	0	0	0	0	0.0%	10	8	80.0%	10	8	80.0%	4	3	75.0%	1	6	0.0	+22	1	32	80.8%
2/3	SAS	W 117-101	30	26	16	0	0	0	1	0	0	0.0%	18	12	66.7%	18	12	66.7%	2	2	100.0%	4	12	0.0	+26	1	34	68.9%
2/1	MEM	W 108-101	21	14	9	2	3	0	2	0	0	0.0%	13	6	46.2%	13	6	46.2%	4	2	50.0%	2	7	1.0	+6	1	16	47.4%
1/31	DET	W 128-121	30	14	11	0	1	1	1	0	0	0.0%	10	7	70.0%	10	7	70.0%	0	0	0.0%	5	6	0.0	+19	2	22	70.0%
1/29	LAC	W 118-108	36	20	17	3	1	1	3	0	0	0.0%	9	6	66.7%	9	6	66.7%	11	8	72.7%	4	13	1.0	+11	3	38	72.3%
1/26	MIL	W 112-100	35	24	14	1	2	1	4	0	0	0.0%	20	9	45.0%	20	9	45.0%	7	6	85.7%	8	6	0.3	+12	4	26	52.0%
1/24	MIL	L 126-116	31	21	12	5	0	0	1	0	0	0.0%	19	10	52.6%	19	10	52.6%	2	1	50.0%	4	8	5.0	-17	0	29	52.8%
1/22	ORL	W 126-99	27	14	11	4	2	0	2	0	0	0.0%	8	6	75.0%	8	6	75.0%	4	2	50.0%	5	6	2.0	+21	2	27	71.7%
1/20	ATL	W 116-95	33	14	11	2	3	3	4	0	0	0.0%	8	6	75.0%	8	6	75.0%	2	2	100.0%	1	10	0.5	+7	2	26	78.8%
1/17	MIL	W 135-95	25	21	13	3	1	0	1	0	0	0.0%	15	9	60.0%	15	9	60.0%	3	3	100.0%	3	10	3.0	+37	0	34	64.3%
1/15	CHI	W 109-91	34	10	14	3	1	2	2	0	0	0.0%	5	4	80.0%	5	4	80.0%	2	2	100.0%	5	9	1.5	+32	1	32	85.0%
1/11	BKN	W 111-102	38	12	12	4	4	2	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	6	6	100.0%	3	9	4.0	+6	5	32	78.5%
1/7	SAS	W 117-115	31	29	16	2	1	1	1	0	0	0.0%	19	11	57.9%	19	11	57.9%	7	7	100.0%	5	11	2.0	-10	3	40	65.7%
1/5	WAS	W 114-90	28	12	12	3	1	2	4	0	0	0.0%	7	5	71.4%	7	5	71.4%	2	2	100.0%	6	6	0.8	+16	2	23	76.1%
1/3	WAS	W 140-101	29	17	19	7	2	0	1	0	0	0.0%	10	7	70.0%	10	7	70.0%	4	3	75.0%	7	12	7.0	+27	0	43	72.3%
1/1	TOR	L 124-121	33	16	11	4	0	1	0	0	0	0.0%	11	5	45.5%	11	5	45.5%	8	6	75.0%	3	8	0.0	-3	4	25	55.1%
12/29	MIL	L 119-111	40	30	12	6	2	0	0	0	0	0.0%	17	15	88.2%	17	15	88.2%	0	0	0.0%	3	9	0.0	-12	2	50	88.2%
12/27	DAL	W 113-110	35	24	23	6	0	2	4	0	0	0.0%	17	9	52.9%	17	9	52.9%	6	6	100.0%	9	14	1.5	+14	1	44	61.1%
12/23	CHI	W 109-95	34	19	17	7	1	1	0	1	0	0.0%	8	6	75.0%	9	6	66.7%	10	7	70.0%	8	9	0.0	+6	0	45	70.9%
12/21	NOP	L 123-104	26	14	7	3	0	1	1	0	0	0.0%	8	7	87.5%	8	7	87.5%	0	0	0.0%	1	6	3.0	-6	0	25	87.5%
12/20	UTA	W 124-116	29	17	8	3	0	2	2	0	0	0.0%	13	8	61.5%	13	8	61.5%	2	1	50.0%	3	5	1.5	-4	1	27	61.2%
12/18	HOU	W 135-130	28	10	6	2	2	0	1	0	0	0.0%	7	3	42.9%	7	3	42.9%	7	4	57.1%	2	4	2.0	-4	5	11	49.6%
12/16	ATL	W 127-119	34	25	14	1	1	2	4	0	0	0.0%	14	12	85.7%	14	12	85.7%	1	1	100.0%	4	10	0.3	+5	1	39	86.6%
12/14	BOS	L 116-107	39	8	10	3	0	0	3	0	0	0.0%	7	4	57.1%	7	4	57.1%	0	0	0.0%	1	9	1.0	-1	1	13	57.1%
12/12	BOS	L 120-113	36	14	5	5	2	3	2	0	0	0.0%	9	6	66.7%	9	6	66.7%	5	2	40.0%	2	3	2.5	+4	4	20	62.5%
12/11	ORL	L 104-94	15	4	7	1	0	1	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	0	0	0.0%	2	5	1.0	-15	6	4	66.7%
12/8	MIA	W 111-99	25	6	9	1	0	1	0	0	0	0.0%	9	3	33.3%	9	3	33.3%	2	0	0.0%	2	7	0.0	-2	2	7	30.4%
12/6	ORL	W 121-111	19	8	11	2	0	1	4	0	0	0.0%	5	4	80.0%	5	4	80.0%	0	0	0.0%	2	9	0.5	+2	5	10	80.0%
12/2	DET	W 110-101	34	19	11	3	0	1	2	0	0	0.0%	9	8	88.9%	9	8	88.9%	5	3	60.0%	5	6	1.5	+4	2	32	84.8%
11/30	POR	L 103-95	38	12	10	2	2	0	1	0	0	0.0%	9	6	66.7%	9	6	66.7%	0	0	0.0%	6	4	2.0	-3	3	21	66.7%
11/28	ATL	W 128-105	29	11	8	2	0	0	0	0	0	0.0%	6	5	83.3%	6	5	83.3%	1	1	100.0%	1	7	0.0	+16	4	19	85.4%
11/26	TOR	W 105-102	26	18	4	3	2	0	2	0	0	0.0%	10	9	90.0%	10	9	90.0%	0	0	0.0%	3	1	1.5	-13	4	24	90.0%
11/25	LAL	L 121-115	37	21	14	3	2	3	2	0	0	0.0%	12	9	75.0%	12	9	75.0%	4	3	75.0%	5	9	1.5	-3	3	35	76.3%
11/22	MIA	L 129-96	22	4	4	2	0	0	3	0	0	0.0%	2	1	50.0%	2	1	50.0%	2	2	100.0%	0	4	0.7	-24	2	8	69.4%
11/21	PHI	W 122-119	35	26	13	3	0	0	2	0	0	0.0%	20	12	60.0%	20	12	60.0%	2	2	100.0%	6	7	1.5	-6	4	27	62.3%
11/19	DEN	W 121-109	29	15	5	5	0	1	2	0	0	0.0%	10	6	60.0%	10	6	60.0%	6	3	50.0%	2	3	2.5	+42	3	16	59.3%
11/17	DET	W 108-100	32	10	7	2	5	0	2	0	0	0.0%	8	4	50.0%	8	4	50.0%	3	2	66.7%	1	6	1.0	+5	1	20	53.6%
11/15	POR	W 109-95	29	11	9	1	3	0	3	0	0	0.0%	3	3	100.0%	3	3	100.0%	6	5	83.3%	1	8	0.3	+0	3	22	97.5%
11/13	SAC	L 132-120	22	12	9	1	0	0	2	0	0	0.0%	6	5	83.3%	6	5	83.3%	3	2	66.7%	4	5	0.5	-25	2	19	82.0%
11/11	GSW	W 118-110	28	12	5	4	0	0	1	0	0	0.0%	6	2	33.3%	6	2	33.3%	9	8	88.9%	3	2	4.0	+13	4	17	60.2%
11/8	OKC	L 128-120	25	14	6	1	1	2	1	0	0	0.0%	6	4	66.7%	6	4	66.7%	9	6	66.7%	4	2	1.0	-4	0	23	70.3%
11/5	GSW	W 115-104	27	12	9	3	0	0	2	0	0	0.0%	7	5	71.4%	7	5	71.4%	2	2	100.0%	5	4	1.5	+9	1	22	76.1%
11/3	IND	L 121-116	21	10	7	0	2	1	1	0	0	0.0%	6	4	66.7%	6	4	66.7%	3	2	66.7%	2	5	0.0	-1	4	15	68.3%
Regular Season Totals			31.7	16.5	10.5	2.7	1.1	0.7	1.6	0.1	0.0	0.0%	10.6	6.7	63.8%	10.6	6.7	63.4%	4.1	3.0	74.2%	3.2	7.4	1.7	+200	1.9	29.3	66.4%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/27	ORL	L 112-89	28	21	9	0	0	1	1	0	0	0.0%	11	8	72.7%	11	8	72.7%	7	5	71.4%	0	9	0.0	-10	1	29	74.6%
4/25	ORL	L 121-83	24	15	8	0	1	0	2	0	0	0.0%	6	5	83.3%	6	5	83.3%	5	5	100.0%	3	5	0.0	-20	2	26	91.5%
4/22	ORL	W 96-86	38	16	20	3	3	2	2	0	0	0.0%	10	6	60.0%	10	6	60.0%	8	4	50.0%	9	11	1.5	+12	4	37	59.2%
4/20	ORL	W 97-83	35	16	18	2	0	2	0	0	0	0.0%	10	6	60.0%	10	6	60.0%	6	4	66.7%	3	15	0.0	+10	1	34	63.3%
Postseason Totals			31.7	17.0	13.8	1.3	1.0	1.3	1.3	0.0	0.0	0.0%	9.3	6.3	67.6%	9.3	6.3	67.6%	6.5	4.5	69.2%	3.8	10.0	1.0	-8	2.0	34.3	70.2%

Jarrett Allen

#31 C

Status

Previous game (@ ORL 4/27)

Latest Jarrett Allen news

Agrees to three-year extension

2023-24 Postseason Stats

2023-24 Season Stats

Jarrett Allen Career Stats

Career Averages

Career Averages

Jarrett Allen Season Stats 2023-24

Previous Game (vs. CHA 4/14)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

Jarrett Allen Game Log 2023-24

Jarrett Allen Player Profile

Career History

Jarrett Allen Fantasy Projections

It's the offseason! 😎

Jarrett Allen Latest News

Agrees to three-year extension

Remains out for Game 5

Questionable for Game 5

Remains out for Game 4

Present for shootaround

Questionable once more

Ruled out for Game 3

Gets another questionable tag

Ruled out for Game 2

Jarrett Allen

#31 C

Unlock the latest Cleveland Cavaliers news — direct to your inbox.

Status

Previous game (@ ORL 4/27)

Latest Jarrett Allen news Subscribe

2023-24 Postseason Stats

2023-24 Season Stats

Latest Jarrett Allen news